SCHEMBL22910225

SCHEMBL22910225

Cc1ccc(-c2ccc3c(c2-c2ccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)cc2)-c2ccccc2C3(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.36
NPC1 O15118 6/20 0.36
RAB9A P51151 6/20 0.36
NFKB1 P19838 3/20 0.36
NFKB2 Q00653 3/20 0.36
RELA Q04206 3/20 0.36
ALDH1A1 P00352 1/20 0.36
NR1H2 P55055 2/20 0.35
NR1H3 Q13133 2/20 0.35
ATM Q13315 2/20 0.35
XBP1 P17861 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
DPP4 P27487 1/20 0.34
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
SMN1; SMN2 Q16637 4/20 0.34
MAPT P10636 4/20 0.34
LMNA P02545 3/20 0.34
CYP1A2 P05177 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22910308 0.94 MEN1 (0.38) L3MBTL1NPC1RAB9AALDH1A1ATM
SCHEMBL22910219 0.94 MEN1 (0.38) L3MBTL1NPC1RAB9AALDH1A1ATM
SCHEMBL17151654 0.89 SMN1; SMN2 (0.40) L3MBTL1NPC1RAB9ANFKB1NFKB2
SCHEMBL22910218 0.88 SMN1; SMN2 (0.39) NPC1RAB9ANFKB1NFKB2RELA
SCHEMBL17151726 0.88 MEN1 (0.39) L3MBTL1NPC1RAB9ANFKB1NFKB2
SCHEMBL22910392 0.87 MAPT (0.39) L3MBTL1NPC1RAB9AALDH1A1XBP1
SCHEMBL22910227 0.87 RAB9A (0.39) L3MBTL1NPC1RAB9AALDH1A1HTT
SCHEMBL22910220 0.85 PDK2 (0.41) L3MBTL1NPC1RAB9AALDH1A1HTT
SCHEMBL22910377 0.85 ABCG2 (0.38) ABCG2PDK2
SCHEMBL22910192 0.84 MEN1 (0.37) L3MBTL1ALDH1A1ATMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11569453-B2 Polycyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2023-01-31 US disclosed
US-20210020848-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2021-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210020848-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME PPOX, NFE2L2, OGFOD1 L3MBTL1 1574/4885NPC1 2747/4885RAB9A 4703/4885
US-11569453-B2 Polycyclic compound and organic light emitting element comprising same PPOX, NFE2L2, OGFOD1 L3MBTL1 1574/4885NPC1 2747/4885RAB9A 4703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.